← Back to headlines
Novo Nordisk's Ozempic price cut boosts sales in India
Novo Nordisk has seen a significant increase in sales of its obesity drug, Ozempic, in India following a recent price reduction.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
